| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.12.24 | Nasdaq Stockholm AB: Listing of Intea Fastigheter AB (publ) on Nasdaq Stockholm | 51 | GlobeNewswire (Europe) | Nasdaq Stockholm AB has assessed that Intea Fastigheter AB (publ), company registration number 559027-5656, fulfills Nasdaq Stockholm's listing requirements. Provided that Intea Fastigheter AB (publ)... ► Artikel lesen | |
| 06.12.24 | Nasdaq Stockholm AB: Reverse Split and Change of ISIN for Tangiamo Touch Technology AB | 93 | GlobeNewswire (Europe) | Referring to the press release from Tangiamo Touch Technology AB from December 5, 2024, the company will carry out a reverse stock split in relations 1:1000. The share will be traded under new ISIN... ► Artikel lesen | |
| 06.12.24 | Covenant Logistics Group, Inc.: Covenant Logistics Group Announces Two-For-One Stock Split | 200 | GlobeNewswire (Europe) | CHATTANOOGA, Tenn., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. (NYSE: CVLG) ("Covenant" or the "Company") announced today that its board of directors has declared a two-for-one... ► Artikel lesen | |
| 06.12.24 | Athira Pharma, Inc.: Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association's 35th International Symposium on ALS/MND | 153 | GlobeNewswire (Europe) | BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and... ► Artikel lesen | |
| 06.12.24 | Zevra Therapeutics Announces Organizational Changes | 134 | GlobeNewswire (Europe) | CELEBRATION, Fla., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on addressing unmet needs for the treatment... ► Artikel lesen | |
| 06.12.24 | BioAge Labs, Inc.: BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity | 142 | GlobeNewswire (Europe) | Decision follows observations of liver transaminitis without clinically significant symptoms in some subjects on azelaprag Company will evaluate data from patients enrolled to date and share updated... ► Artikel lesen | |
| 06.12.24 | Cerence AI Announces Equity Grant to Employee Under Inducement Plan Pursuant to Nasdaq Listing Rule 5635(c)(4) | 240 | GlobeNewswire (Europe) | BURLINGTON, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) ("Cerence AI"), a global industry leader in AI for transportation, today announced that, in connection with Antonio... ► Artikel lesen | |
| 06.12.24 | Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 234 | GlobeNewswire (Europe) | BRISBANE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| 06.12.24 | Osisko Metals Incorporated: Osisko Metals Acquires Additional Claims Near Gaspé Copper | 155 | GlobeNewswire (Europe) | MONTREAL, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company or "Osisko Metals") (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce the acquisition of a group... ► Artikel lesen | |
| 06.12.24 | Dynamix Corporation Announces the Separate Trading of its Class A ordinary shares and Warrants Commencing December 9, 2024 | 106 | GlobeNewswire (Europe) | Houston, TX, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Dynamix Corporation (the "Company") today announced that commencing December 9, 2024, holders of the units sold in the Company's initial public offering... ► Artikel lesen | |
| 06.12.24 | Freight App, Inc.: Freight Technologies Provides Update on its Public Filings Procedures | 149 | GlobeNewswire (Europe) | HOUSTON, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (Nasdaq: FRGT, "Fr8Tech" or the "Company"), a logistics management innovation company, offering a diverse portfolio of technology-driven... ► Artikel lesen | |
| 06.12.24 | Codexis, Inc.: Codexis Announces New Employment Inducement Grants | 138 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced... ► Artikel lesen | |
| 06.12.24 | Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 167 | GlobeNewswire (Europe) | WALTHAM Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company approved... ► Artikel lesen | |
| 06.12.24 | Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 115 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on December 4, 2024, the Compensation Committee of Adverum's Board of Directors... ► Artikel lesen | |
| 06.12.24 | NurExone Biologic Inc: NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage | 243 | GlobeNewswire (Europe) | TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing... ► Artikel lesen | |
| 06.12.24 | Chimerix, Inc.: Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 227 | GlobeNewswire (Europe) | DURHAM, N.C., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on December 2, 2024, the Compensation Committee of Chimerix's Board of Directors granted inducement awards... ► Artikel lesen | |
| 06.12.24 | Xenon Pharmaceuticals Inc.: Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024 | 140 | GlobeNewswire (Europe) | - OLE data shows sustained monthly reduction in seizure frequency, impressive seizure freedom rates, and consistent AE safety profile suggesting long-term efficacy and tolerability of azetukalner... ► Artikel lesen | |
| 06.12.24 | NewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 91 | GlobeNewswire (Europe) | NAARDEN, The Netherlands and MIAMI, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam" or the "Company"), a late-stage, clinical biopharmaceutical company... ► Artikel lesen | |
| 06.12.24 | Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 145 | GlobeNewswire (Europe) | WESTLAKE VILLAGE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations... ► Artikel lesen | |
| 06.12.24 | Credit Agricole Sa: Crédit Agricole entered into financial instruments relating to 5.2% of Banco BPM's share capital | 171 | GlobeNewswire (Europe) | Montrouge, 6th december 2024 Crédit Agricole entered into financial instruments relating to 5.2% of Banco BPM's share capital Crédit Agricole S.A. ("Crédit Agricole") has notified the Italian Authority... ► Artikel lesen |
Seite:
1 2 3 4 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| D-WAVE QUANTUM | 4.929 |
| BAYER | 4.162 |
| NEL | 3.313 |
| NVIDIA | 3.032 |
| EVOTEC | 2.379 |
| TESLA | 1.880 |
| DEUTSCHE BANK | 1.794 |
| TUI | 1.700 |
| PLUG POWER | 1.622 |
| COMMERZBANK | 1.587 |
| DEUTSCHE LUFTHANSA | 1.547 |
| NOVO NORDISK | 1.404 |
| RENK GROUP | 1.209 |
| VOLKSWAGEN | 1.182 |
| BASF | 1.152 |
| KONTRON | 1.068 |
| NORDEX | 1.057 |
| RHEINMETALL | 1.017 |
| BYD | 995 |
| RWE | 967 |
| MERCEDES-BENZ | 957 |
| BIONTECH | 874 |
| DEUTSCHE TELEKOM | 813 |
| MICROSTRATEGY | 771 |
| THYSSENKRUPP | 757 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
